Ankur A. Doshi

Ankur A. Doshi

Auto-generated profile, based on publicly available information

Ankur A. Doshi

Department of Emergency Medicine (A.A.D.), University of Pittsburgh School of Medicine, PA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ADAnkur Doshi
Ankur Doshi
MZMaggie Yuxi Zhou
Maggie Yuxi Zhou
NBNam Quoc Bui
Nam Quoc Bui
DWDavid S. Wang
David S. Wang
KGKristen N. Ganjoo
Kristen N. Ganjoo
GHGloria L. Hwang
Gloria L. Hwang

29 January 2024 in Clinical and Experimental Emergency Medicine
Verified
Journal Article
Open access
PDF file
PCPatrick Coppler
Patrick Coppler
DGDavid J. Gagnon
David J. Gagnon
KFKatharyn L. Flickinger
Katharyn L. Flickinger
JEJonathan Elmer
Jonathan Elmer
CCClifton W. Callaway
Clifton W. Callaway
JRJon C. Rittenberger
Jon C. Rittenberger
Objective We hypothesized that the administration of amantadine would increase awakening of comatose patients resuscitated from cardiac arrest. Methods We performed a prospective, randomized, controlled pilot trial, randomizing subjects to amantadine 100 mg twice daily or placebo for up to 7 days. The study drug was administered between 72 and 120 hours after resuscitation and patients with absent N20 cortical responses, early cerebral edema, or ongoing malignant electroencephalography patterns were excluded. Our primary outcome was awakening, defined as following two-step commands, within 28 days of cardiac arrest. Secondary outcomes included length of stay, awakening, time to awakening, and neurologic outcome measured by Cerebral Performance Category at hospital discharge. We compared the proportion of subjects awakening and hospital survival using Fisher exact tests and time to awakening and hospital length of stay using Wilcoxon rank sum tests. Results After 2 years, we stopped the study due to slow enrollment and lapse of funding. We enrolled 14 subjects (12% of goal enrollment), seven in the amantadine group and seven in the placebo group. The proportion of patients who awakened within 28 days after cardiac arrest did not differ between amantadine (n=2, 28.6%) and placebo groups (n=3, 42.9%; P>0.99). There were no differences in secondary outcomes. Study medication was stopped in three subjects (21.4%). Adverse events included a recurrence of seizures (n=2; 14.3%), both of which occurred in the placebo group.

1 June 2021 in Resuscitation
Verified
Journal Article
Closed access
JRJon C. Rittenberger
Jon C. Rittenberger
AWAlexandra Weissman
Alexandra Weissman
KFKatharyn L. Flickinger
Katharyn L. Flickinger
FGFrancis X. Guyette
Francis X. Guyette
DHDavid Hopkins
David Hopkins
CCClifton W. Callaway
Clifton W. Callaway

1 January 2026 in Circulation: Population Health and Outcomes
Verified
Journal Article
Closed access
OFOre Fawole
Ore Fawole
SOSylvia Owusu-Ansah
Sylvia Owusu-Ansah
ADAnkur A. Doshi
Ankur A. Doshi
BHBeth L. Hoffman
Beth L. Hoffman

1 December 2015 in Critical Care
Verified
Journal Article
Open access
PDF file
JEJonathan Elmer
Jonathan Elmer
BWBo Wang
Bo Wang
SMSamer Melhem
Samer Melhem
RPRaghavesh Pullalarevu
Raghavesh Pullalarevu
NVNishit Vaghasia
Nishit Vaghasia
O(on behalf of the University of Pittsburgh Post-Cardiac Arrest Service (PCAS)
on behalf of the University of Pittsburgh Post-Cardiac Arrest Service (PCAS)
Unfortunately, the original version of this article [1] contained an error. The spelling of the author Raghavesh Pullalarevu's name was incorrect. The correct spelling is Raghavesh Pullalarevu rather than "Raghevesh Pullalarevu" which was used in the published article.

1 December 2012 in Critical Care Medicine
Verified
Journal Article
Closed access
JYJoseph Yanta
Joseph Yanta
FGFrancis Guyette
Francis Guyette
ADAnkur Doshi
Ankur Doshi
CCClifton Callaway
Clifton Callaway
JRJon Rittenberger
Jon Rittenberger
Cardiac arrest is common in North America and the frequency of renal dysfunction in patients with out-of-hospital cardiac arrest (OHCA) is not well established. Renal dysfunction has been associated with worse outcomes in critical illness. Renal dysfunction is common after OHCA, and renal dysfunction is independently associated with survival. We performed a retrospective review of consecutive adult patients admitted to an ICU after successful resuscitation from OHCA between 1/1/2005 and 12/31/2010. Subjects were excluded for death or withdrawal of care within 24 hours, preexisting end-stage renal disease (ESRD), or OHCA due to hyperkalemia. Renal injury was defined using the RIFLE criteria and subjects classified into one of three categories – Risk, Injury, or Failure – based on trending of serum creatinine or glomerular filtration rate. Data were analyzed using descriptive statistics. Logistic regression was used to determine predictors of survival. Candidate variables included age, gender, renal failure, rhythm of arrest, and category of initial illness severity. Of 364 patients, 38 were excluded due to early death or withdrawal of care, 11 due to ESRD, and 4 due to OHCA due to hyperkalemia leaving 311 patients in the final analysis. The median age was 58 (SD 16) years; 174 (59%) were male, VF/VT was the primary rhythm in 156 (50%), and 236 (80%) were comatose following resuscitation. Based on the RIFLE criteria, 32 (10.3%) developed acute renal failure (ARF), 27 (8.7%) developed acute kidney injury, and 56 (18.0%) developed risk of renal dysfunction. Renal replacement therapy was initiated on 13 of 32 (40.6%) subjects with ARF. Development of ARF was not associated with survival (OR 0.73; 95% CI 0.26, 2.05). A primary rhythm of VF/VT (OR 3.92; 95% CI 2.16, 7.13), category I illness severity (OR 12.7; 95% CI 2.92, 55.13), and category IV illness severity (OR 0.18; 95% CI 0.06, 0.60) were associated with survival. More than one-third of patients resuscitated from OHCA developed evidence of renal dysfunction, and 19% of patients developed clinically significant renal dysfunction. Development of renal failure was not independently associated with survival.